TGF-β1 has been demonstrated to suppress INF-γ production by CD8+ T cells and to promote, in concert with IL-6, IL-1β, and IL-10, Treg generation, and Th17 differentiation, thus favoring tumor growth and progression [75, 90–92]. This evidence concerns the gene IL1B and neoplasm.